• Exchange: Toronto
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Oncolytics Biotech Inc

+ Add to Watchlist


0.5500 CAD 0.0200 3.77%

As of 15:59:54 ET on 10/23/2014.

Snapshot for Oncolytics Biotech Inc (ONC)

Open: 0.5300 Day's Range: 0.5100 - 0.5500 Volume: 64,328
Previous Close: 0.5300 52wk Range: 0.4450 - 3.0000 1-Yr Rtn: -80.84%

Stock Chart for ONC

No chart data available.
  • ONC:CN 0.5500
  • 1D
  • 1M
  • 1Y
Interactive ONC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ONC

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPTSX -
Earnings Per Share (CAD) (ttm) -0.2500
Est. EPS (CAD) (12/2014) -0.2560
Est. PEG Ratio -
Market Cap (M CAD) 48.98
Shares Outstanding (M) 89.06
30 Day Average Volume 252,713
Price/Book (mrq) 2.9394
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ONC

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for ONC

Oncolytics Biotech Inc. discovers and develops pharmaceutical products for the treatment of cancers that have not been successfully treated with conventional therapeutics. The Company is focusing on the development of the reovirus known as REOLYSIN as a potential cancer therapeutic.

Bradley G Thompson "Brad"Chairman/President/CEOKirk LookChief Financial Officer
Matthew C Coffey "Matt"COO/Co-FounderAlan J TuchmanSenior VP:Clinical/Chief Medical Ofcr
More Company Profile & Key Executives for ONC

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil